Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Clustering of cardiovascular risk factors: Targeting high-risk individuals
1995
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome
2016 Standout
Triglycerides and Cardiovascular Disease
2011
Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men
1994
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Healthy Dietary Interventions and Lipoprotein (a) Plasma Levels: Results from the Omni Heart Trial
2014
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis
1995
The metabolic syndrome
2010 Standout
Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine study
1996 Standout
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
1994 Nature
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
2003 Standout
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
2006 Standout
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies* on Coronary Prevention
1998
Trans Polyunsaturated Fatty Acids Have More Adverse Effects than Saturated Fatty Acids on the Concentration and Composition of Lipoproteins Secreted by Human Hepatoma HepG2 Cells
2002
High-density lipoproteins and atherosclerosis
2002
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: The InChianti study
2006
Prevalence of risk factors in men with premature coronary artery disease
1991
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
2002
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Artificial Intelligence in Precision Cardiovascular Medicine
2017 Standout
The metabolic syndrome
2005 Standout
Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer
2002 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
High–monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations
1999 Standout
Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension
1994
The immune response in atherosclerosis: a double-edged sword
2006 Standout
High density lipoproteins and coronary heart disease
1996
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels
1996
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
1992
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Polyunsaturated fatty acids result in greater cholesterol lowering and less triacylglycerol elevation than do monounsaturated fatty acids in a dose-response comparison in a multiracial study group
1995
Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials
2001
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
2003 Standout
Atherosclerosis
2000 StandoutNature
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Atherosclerosis
2001 Standout
Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux
1999
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis
1995
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models
1999
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Excess of Rare Amino Acid Polymorphisms in the Toll-like Receptor 4 in Humans
2001 StandoutNobel
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Hypercholesterolemic effect of dietary cholesterol in diets enriched in polyunsaturated and saturated fat. Dietary cholesterol, fat saturation, and plasma lipids.
1994
Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes
1996
Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors
2006 Standout
Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
2002
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Fuzzy expert system approach for coronary artery disease screening using clinical parameters
2012
Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL
2001
Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.
1986
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
2004
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
1999
The Relation of Overweight to Cardiovascular Risk Factors Among Children and Adolescents: The Bogalusa Heart Study
1999 Standout
Cardiovascular Disease Mortality in Familial Forms of Hypertriglyceridemia: A 20-Year Prospective Study
2000
Effects of Endurance Exercise Training on Plasma HDL Cholesterol Levels Depend on Levels of Triglycerides
2001
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
Severe Atherosclerosis and Hypoalphalipoproteinemia in the Staggerer Mouse, a Mutant of the Nuclear Receptor RORα
1998
Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With Hypertriglyceridemia
1996
Effects of Reducing Dietary Saturated Fatty Acids on Plasma Lipids and Lipoproteins in Healthy Subjects
1998
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
The Metabolic Syndrome
2008 Standout
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
2003 Standout
Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans.
1994
Task force 4. Efficacy of risk factor management
1996
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins
1999
VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial
2000
General Cardiovascular Risk Profile for Use in Primary Care
2008 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Antiinflammatory Properties of HDL
2004 Standout
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
Arterial Compliance in Obese Subjects Is Improved With Dietary Plant n-3 Fatty Acid From Flaxseed Oil Despite Increased LDL Oxidizability
1997
The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels
2005
Works of E Schaefer being referenced
Comparison of the Effects of Pravastatin and Lovastatin on Sleep Disturbance in Hypercholesterolemic Subjects
1999
Effects of dietary fat saturation on plasma lipoprotein(a) and hepatic apolipoprotein(a) mRNA concentrations in cynomolgus monkeys
1994
Dietary cholesterol increases the susceptibility of low density lipoprotein to oxidative modification
2000
Effect of hospitalization on high-density lipoprotein cholesterol in patients undergoing elective coronary angiography
1988
Dietary Monounsaturated and Polyunsaturated Fatty Acids are Comparable in their Effects on Hepatic Apolipoprotein mRNA Abundance and Liver Lipid Concentrations when Substituted for Saturated Fatty Acids in Cynomolgus Monkeys
1995
Familial lipoprotein disorders in patients with premature coronary artery disease.
1992
Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a National Cholesterol Education Program Step 2 diet.
1993
Abetalipoproteinemia and Metastatic Spinal Cord Glioblastoma
1984
Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease
1991